Annual report
9220.TEDINET S100YK1M
Period2025-04-01 → 2026-03-31
Filed2026-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 147
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.5bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥11.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥10.4bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.6bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.2bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥635m | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥660m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥826m | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥679m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥802m | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥737m | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥648m | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥685m | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥595m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥464m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥406m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥523m | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥445m | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥529m | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥464m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥406m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥9.3bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥8.9bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥9.5bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥9.0bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥7.7bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.4bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥5.2bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.9bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.6bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.5bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥3.0bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.0bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.2bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.9bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.6bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.3bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥970m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥899m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥411m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥240m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥586m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥849m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥97m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥767m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥472m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥464m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥879m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥187.51 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥152 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥195.6 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥167.39 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥240.32 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,612.43 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,447.37 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,299.91 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,135.13 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥913.16 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 42.1% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.6% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.7% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.1% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 12.3% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.4% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.1% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.6% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 30.3% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 993 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 1,001 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 1,060 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 1,011 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 985 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥10.8bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥10.3bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥9.8bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥9.3bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.8bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥619m | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥647m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥799m | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥657m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥767m | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥713m | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥578m | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥658m | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥573m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥438m | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥393m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥519m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥461m | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥368m | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥9.1bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥8.6bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥9.3bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.9bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.5bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.3bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.1bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.8bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.5bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.4bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥2.9bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.9bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥176.8 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥147.19 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥194.05 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥173.29 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥167.07 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥38 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥33 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥33 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥33 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,553.55 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,400.89 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,261.02 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,097.79 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥860.61 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 41.7% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.8% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.3% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.2% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.2% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 12.0% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.4% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.5% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.1% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.5% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,436,700 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,676,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,676,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,676,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,200,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 923 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 939 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 979 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 952 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 938 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥62m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥2.9bn |
| Nursing Care Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥329m |
| Nursing Care Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥344m |
| Nursing Care Businessreportable segment | employees | at 2026-03-31 | 665 pure |
| Nursing Care Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥6.6bn |
| Nursing Care Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥6.6bn |
| Nursing Care Businessreportable segment | segment assets | at 2026-03-31 | ¥5.0bn |
| Nursing Care Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥314m |
| Nursing Care Equipment Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥229m |
| Nursing Care Equipment Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥42m |
| Nursing Care Equipment Businessreportable segment | employees | at 2026-03-31 | 276 pure |
| Nursing Care Equipment Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥5.0bn |
| Nursing Care Equipment Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥5.0bn |
| Nursing Care Equipment Businessreportable segment | segment assets | at 2026-03-31 | ¥1.5bn |
| Nursing Care Equipment Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥321m |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥558m |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥387m |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥11.5bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥11.5bn |
| —segment total | segment assets | at 2026-03-31 | ¥6.5bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥635m |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥940,000 |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥2.5bn |
| Nursing Care Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥247m |
| Nursing Care Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥344m |
| Nursing Care Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥6.4bn |
| Nursing Care Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥6.4bn |
| Nursing Care Businessreportable segment | segment assets | at 2025-03-31 | ¥5.1bn |
| Nursing Care Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥346m |
| Nursing Care Equipment Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥3m |
| Nursing Care Equipment Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥30m |
| Nursing Care Equipment Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥4.6bn |
| Nursing Care Equipment Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥4.6bn |
| Nursing Care Equipment Businessreportable segment | segment assets | at 2025-03-31 | ¥1.2bn |
| Nursing Care Equipment Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥314m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥250m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥374m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥11.0bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥11.0bn |
| —segment total | segment assets | at 2025-03-31 | ¥6.3bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥660m |
| Nursing Care Businessreportable segment | employees | at 2026-03-31 | 598 pure |
| Nursing Care Equipment Businessreportable segment | employees | at 2026-03-31 | 273 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,499
| Item | Context | Value | Unit |
|---|---|---|---|
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row4Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row5Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row6Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Basic policy on human resources strategy employees etc (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in accounting estimates consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding accumulated depreciation of property plant and equipment (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding pledged assets (text) | CurrentYearInstant | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding reclassification adjustments income taxes and tax effects relating to other comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Major components of assets and liabilities increased or decreased as result of acquisition or disposal of business or merger etc whereby cash was paid or received as consideration (text) | CurrentYearDuration | Text · Plus | |
| Description of significant transactions not requiring use of cash or cash equivalents (text) | CurrentYearDuration | Text · Plus | |
| Notes leases consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes derivatives consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes retirement benefits consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes share options etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |